Who are RecFSH / follitropin beta's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Placebo, gonadotropins in step-up regimen, fix dose r-FSH (Gonal-f), MENOPUR; GONAL-F, rFSH drug dose, Gonal-f® RFF, rhFSH+rhLH.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/recfsh-follitropin-beta.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

RecFSH / follitropin beta — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RecFSH / follitropin beta (RecFSH / follitropin beta) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Health.

phase 3 Gonadotropin FSH receptor Reproductive Health Biologic Live · refreshed every 30 min

Target snapshot

RecFSH / follitropin beta (RecFSH / follitropin beta) — Organon and Co. RecFSH / follitropin beta stimulates the production of follicle-stimulating hormone, promoting ovulation and follicular growth.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
RecFSH / follitropin beta TARGET	RecFSH / follitropin beta	Organon and Co	phase 3	Gonadotropin	FSH receptor
Placebo, gonadotropins in step-up regimen	Placebo, gonadotropins in step-up regimen	University of Modena and Reggio Emilia	marketed	Gonadotropin	FSH receptor, LH receptor
fix dose r-FSH (Gonal-f)	fix dose r-FSH (Gonal-f)	Sisli Hamidiye Etfal Training and Research Hospital	marketed	Gonadotropin	FSH receptor (FSHR)
MENOPUR; GONAL-F	MENOPUR; GONAL-F	Central Jutland Regional Hospital	marketed	Gonadotropin	FSH receptor (FSHR); LH receptor (LHCGR) for MENOPUR
rFSH drug dose	rFSH drug dose	Nina la Cour Freiesleben	marketed	Gonadotropin	FSH receptor (FSHR)
Gonal-f® RFF	Gonal-f® RFF	Fertility Biotech AG	marketed	Gonadotropin; recombinant FSH	FSH receptor (FSHR)
rhFSH+rhLH	rhFSH+rhLH	Fundación Santiago Dexeus Font	marketed	Gonadotropin	FSH receptor and LH receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin class)

Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
Organon and Co · 3 drugs in this class
Fundación Santiago Dexeus Font · 3 drugs in this class
Merck KGaA · 2 drugs in this class
Nina la Cour Freiesleben · 2 drugs in this class
IVI Madrid · 2 drugs in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). RecFSH / follitropin beta — Competitive Intelligence Brief. https://druglandscape.com/ci/recfsh-follitropin-beta. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab